Quantum Genomics SA (PA:ALQGC) — Market Cap & Net Worth
Market Cap & Net Worth: Quantum Genomics SA (ALQGC)
Quantum Genomics SA (PA:ALQGC) has a market capitalization of $5.03 Million (€4.30 Million) as of May 4, 2026. Listed on the PA stock exchange, this France-based company holds position #28352 globally and #516 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Quantum Genomics SA's stock price €0.07 by its total outstanding shares 69709954 (69.71 Million). Analyse ALQGC cash flow metrics to see how efficiently the company converts income to cash.
Quantum Genomics SA Market Cap History: 2015 to 2026
Quantum Genomics SA's market capitalization history from 2015 to 2026. Data shows change from $690.36 Million to $5.87 Million (-36.56% CAGR).
Quantum Genomics SA Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Quantum Genomics SA's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
587602.47x
Quantum Genomics SA's market cap is 587602.47 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $690.36 Million | $144.14K | -$3.76 Million | 4789.55x | N/A |
| 2018 | $435.20 Million | $3.69K | -$11.99 Million | 118068.56x | N/A |
| 2019 | $275.46 Million | $1.55 Million | -$9.08 Million | 178.06x | N/A |
| 2020 | $399.34 Million | $1.83 Million | -$16.22 Million | 218.34x | N/A |
| 2021 | $349.30 Million | $3.14 Million | -$17.36 Million | 111.31x | N/A |
| 2022 | $9.62 Million | $2.52 Million | -$24.94 Million | 3.82x | N/A |
| 2023 | $8.64 Million | $19.80K | -$3.17 Million | 436.39x | N/A |
| 2024 | $5.88 Million | $10.00 | -$8.89 Million | 587602.47x | N/A |
Competitor Companies of ALQGC by Market Capitalization
Companies near Quantum Genomics SA in the global market cap rankings as of May 4, 2026.
Key companies related to Quantum Genomics SA by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #223 globally with a market cap of $107.56 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #367 globally with a market cap of $72.88 Billion USD.
- UCB SA (BR:UCB): Ranked #517 globally with a market cap of $51.45 Billion USD ( €44.01 Billion EUR).
- argenx NV ADR (NASDAQ:ARGX): Ranked #568 globally with a market cap of $45.97 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #223 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $107.56 Billion | $423.92 |
| #367 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $72.88 Billion | $701.42 |
| #517 | UCB SA | BR:UCB | $51.45 Billion | €231.20 |
| #568 | argenx NV ADR | NASDAQ:ARGX | $45.97 Billion | $787.95 |
Quantum Genomics SA Historical Marketcap From 2015 to 2026
Between 2015 and today, Quantum Genomics SA's market cap moved from $690.36 Million to $ 5.87 Million, with a yearly change of -36.56%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €5.87 Million | -0.28% |
| 2025 | €5.88 Million | +0.14% |
| 2024 | €5.88 Million | -31.98% |
| 2023 | €8.64 Million | -10.17% |
| 2022 | €9.62 Million | -97.25% |
| 2021 | €349.30 Million | -12.53% |
| 2020 | €399.34 Million | +44.97% |
| 2019 | €275.46 Million | -36.70% |
| 2018 | €435.20 Million | +69.52% |
| 2017 | €256.72 Million | -57.20% |
| 2016 | €599.83 Million | -13.11% |
| 2015 | €690.36 Million | -- |
End of Day Market Cap According to Different Sources
On May 3rd, 2026 the market cap of Quantum Genomics SA was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $5.03 Million USD |
| MoneyControl | $5.03 Million USD |
| MarketWatch | $5.03 Million USD |
| marketcap.company | $5.03 Million USD |
| Reuters | $5.03 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Quantum Genomics SA
Quantum Genomics Société Anonyme is in the process of liquidation of its remaining assets. Previously, the company was engaged in the development of drugs to treat cardiovascular diseases. Quantum Genomics Société Anonyme was incorporated in 2005 and is headquartered in Paris, France.